Skip to main content

Advertisement

Table 2 Imaging characteristics of patients with myocardial amyloidosis

From: 18F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition

  Patient 1 Patient 2 Patient 5a Patient 7 Patient 9
Echocardiography Moderate concentric LVH with echo-texture suspicious for amyloid Moderate concentric LVH Moderate concentric LVH Moderate concentric LVH with echo-texture suspicious for amyloid Moderate LVH with echo-texture suspicious for amyloid
Cardiac MRI N/A BH with extensive sub-endocardial delayed enhancement consistent with CA N/A N/A N/A
18F-florbetaben PET/MRI Elevated early and delayed uptake in LV Elevated early and delayed uptake in LV Elevated early and delayed uptake in LV Elevated early and delayed uptake in LV Elevated early and delayed uptake in LV
  1. LVH left ventricular hypertrophy, BH biventricular hypertrophy, CA cardiac amyloidosis, LV left ventricle, N/A not available
  2. aMyocardial involvement was proven by biopsy